<?xml version="1.0" encoding="UTF-8"?>
<results title="disease">
 <result pre="Microbiol Infect DisComp. Immunol. Microbiol. Infect. DisComparative Immunology, Microbiology and" exact="Infectious" post="Diseases0147-95711878-1667Elsevier Ltd. pmcid: 7172155S0147-9571(19)30049-9 doi: 10.1016/j.cimid.2019.03.004 : Article Etiology"/>
 <result pre="7172155S0147-9571(19)30049-9 doi: 10.1016/j.cimid.2019.03.004 : Article Etiology and characteristics of community-acquired" exact="pneumonia" post="in an influenza epidemic period LinChun369168231@qq.comb1ChenHuanzhu13592849398@163.comac1HePingphe@stu.edu.cnaLiYazhen742795693@qq.comaKeChangwenkecw1965@aliyun.comaJiaoXiaoyangxyjiao@stu.edu.cna�?�[a], [b], [c], �?�Corresponding"/>
 <result pre="- including this research content - immediately available in PubMed" exact="Central" post="and other publicly funded repositories, such as the WHO"/>
 <result pre="Central and other publicly funded repositories, such as the WHO" exact="COVID" post="database with rights for unrestricted research re-use and analyses"/>
 <result pre="in our study is different from previous study. •4 Yeast," exact="Acinetobacter" post="baumannii and Klebsiella pneumoniae have high positive rate. Abstract"/>
 <result pre="have high positive rate. Abstract Purpose The etiology of community-acquired" exact="pneumonia" post="(CAP) in hospital patients is often ambiguous due to"/>
 <result pre="(CAP) in hospital patients is often ambiguous due to the" exact="limited" post="pathogen detection. Lack of a microbiological diagnosis impairs precision"/>
 <result pre="impairs precision treatment in CAP. Methods Specimens collected from the" exact="lower" post="respiratory tract of 195 CAP patients, viruses were measured"/>
 <result pre="precision treatment in CAP. Methods Specimens collected from the lower" exact="respiratory" post="tract of 195 CAP patients, viruses were measured by"/>
 <result pre="Results Among the 195 patients, there were 46 (23.59%) pure" exact="bacterial infections," post="20 (10.26%) yeast infections, 32 (16.41%) pure viral infections,"/>
 <result pre="pure bacterial infections, 20 (10.26%) yeast infections, 32 (16.41%) pure" exact="viral" post="infections, 8 (4.10%) viral-yeast co-infections, and 17 (8.72%) viral-bacterial"/>
 <result pre="17 (8.72%) viral-bacterial co-infections. The two most abundant bacteria were" exact="Acinetobacter" post="baumannii and klebsiella pneumoniae, whereas the most common virus"/>
 <result pre="whereas the most common virus was influenza A. Conclusions Non-influenza" exact="respiratory" post="microorganisms frequently co-circulated during the epidemic peaks of influenza,"/>
 <result pre="which easily being ignored in CAP therapy. In patients with" exact="bacterial" post="and viral co-infections, identifying the etiologic agent is crucial"/>
 <result pre="being ignored in CAP therapy. In patients with bacterial and" exact="viral" post="co-infections, identifying the etiologic agent is crucial for patient’s"/>
 <result pre="the etiologic agent is crucial for patient’s therapy. Keywords Community-acquired" exact="pneumonia" post="Influenza Respiratory virus bacterial/Yeast infection Co-infections 1 Introduction Community-acquired"/>
 <result pre="agent is crucial for patient’s therapy. Keywords Community-acquired pneumonia Influenza" exact="Respiratory" post="virus bacterial/Yeast infection Co-infections 1 Introduction Community-acquired pneumonia (CAP)"/>
 <result pre="for patient’s therapy. Keywords Community-acquired pneumonia Influenza Respiratory virus bacterial/Yeast" exact="infection" post="Co-infections 1 Introduction Community-acquired pneumonia (CAP) is a common"/>
 <result pre="pneumonia Influenza Respiratory virus bacterial/Yeast infection Co-infections 1 Introduction Community-acquired" exact="pneumonia" post="(CAP) is a common disease and a significant cause"/>
 <result pre="infection Co-infections 1 Introduction Community-acquired pneumonia (CAP) is a common" exact="disease" post="and a significant cause of morbidity and mortality worldwide"/>
 <result pre="of morbidity and mortality worldwide [1]. The severity of the" exact="disease" post="can be affected by various factors including age, immune"/>
 <result pre="mixed infection. The etiology of CAP is essential because most" exact="respiratory" post="illnesses lead to similar clinical presentations. Currently, the ambiguous"/>
 <result pre="therapy [2]. In the last decade, the long-term implications of" exact="respiratory" post="viral infection among susceptible hosts have increasingly been recognized"/>
 <result pre="[2]. In the last decade, the long-term implications of respiratory" exact="viral infection" post="among susceptible hosts have increasingly been recognized [3]. Although"/>
 <result pre="In the last decade, the long-term implications of respiratory viral" exact="infection" post="among susceptible hosts have increasingly been recognized [3]. Although"/>
 <result pre="increasingly been recognized [3]. Although approximately 200 million cases of" exact="viral" post="CAP occur every year, the incidence of viral pneumonia"/>
 <result pre="cases of viral CAP occur every year, the incidence of" exact="viral pneumonia" post="still has been underestimated. In hospital, bacteria remain the"/>
 <result pre="of viral CAP occur every year, the incidence of viral" exact="pneumonia" post="still has been underestimated. In hospital, bacteria remain the"/>
 <result pre="been underestimated. In hospital, bacteria remain the first consideration in" exact="pulmonary" post="infections, and antibiotic therapy is still the cornerstone of"/>
 <result pre="is still the cornerstone of the majority of CAP. Influenza" exact="virus infection" post="(IVI) causes annual epidemics that result in estimated 1"/>
 <result pre="still the cornerstone of the majority of CAP. Influenza virus" exact="infection" post="(IVI) causes annual epidemics that result in estimated 1"/>
 <result pre="250,000–500,000 mortality cases worldwide each year [4]. IVI can cause" exact="primary" post="viral pneumonia, which may progress to a potentially fatal"/>
 <result pre="mortality cases worldwide each year [4]. IVI can cause primary" exact="viral pneumonia," post="which may progress to a potentially fatal outcome [5]."/>
 <result pre="to distinguish the cause of CAP induced by flu, other" exact="respiratory" post="viruses or bacteria based solely on clinical symptoms, and"/>
 <result pre="solely on clinical symptoms, and the conventional lab biomarkers of" exact="viral" post="and/or bacterial infections do not differ in influenza-positive compared"/>
 <result pre="clinical symptoms, and the conventional lab biomarkers of viral and/or" exact="bacterial infections" post="do not differ in influenza-positive compared with influenza-negative patients"/>
 <result pre="symptoms, and the conventional lab biomarkers of viral and/or bacterial" exact="infections" post="do not differ in influenza-positive compared with influenza-negative patients"/>
 <result pre="[6]. Influenza can temporarily suppress host immune defenses, leading to" exact="bacterial" post="complications [7]. Secondary bacterial pneumonia is a frequent cause"/>
 <result pre="temporarily suppress host immune defenses, leading to bacterial complications [7]." exact="Secondary" post="bacterial pneumonia is a frequent cause of excess mortality"/>
 <result pre="suppress host immune defenses, leading to bacterial complications [7]. Secondary" exact="bacterial" post="pneumonia is a frequent cause of excess mortality during"/>
 <result pre="host immune defenses, leading to bacterial complications [7]. Secondary bacterial" exact="pneumonia" post="is a frequent cause of excess mortality during influenza"/>
 <result pre="season showed a moderate to strong association between influenza and" exact="bacterial" post="pneumonia, whereas the interaction is modest or non-existent during"/>
 <result pre="or non-existent during non-epidemic periods [9]. Bacteria including streptococcus pneumoniae," exact="hemophilia" post="influenzae, and staphylococcus aureus, often interact with respiratory viruses"/>
 <result pre="streptococcus pneumoniae, hemophilia influenzae, and staphylococcus aureus, often interact with" exact="respiratory" post="viruses (esp. the influenza virus), and shape the outcome"/>
 <result pre="viruses (esp. the influenza virus), and shape the outcome of" exact="respiratory" post="infection [10]. Studies have shown the evidence of bacterial"/>
 <result pre="(esp. the influenza virus), and shape the outcome of respiratory" exact="infection" post="[10]. Studies have shown the evidence of bacterial invasion"/>
 <result pre="of respiratory infection [10]. Studies have shown the evidence of" exact="bacterial" post="invasion is more than 90% in influenza-infected cases, and"/>
 <result pre="high rates of co-infections exist in these patients, indicating that" exact="viral infection" post="may enhance both susceptibility and severity of subsequent bacterial"/>
 <result pre="rates of co-infections exist in these patients, indicating that viral" exact="infection" post="may enhance both susceptibility and severity of subsequent bacterial"/>
 <result pre="viral infection may enhance both susceptibility and severity of subsequent" exact="bacterial infection" post="[8,11,12]. In vitro studies have shown that influenza infection"/>
 <result pre="infection may enhance both susceptibility and severity of subsequent bacterial" exact="infection" post="[8,11,12]. In vitro studies have shown that influenza infection"/>
 <result pre="bacterial infection [8,11,12]. In vitro studies have shown that influenza" exact="infection" post="enhanced susceptibility to pneumococcal pneumonia by about 100-fold in"/>
 <result pre="[8,11,12]. In vitro studies have shown that influenza infection enhanced" exact="susceptibility to" post="pneumococcal pneumonia by about 100-fold in a week, but"/>
 <result pre="vitro studies have shown that influenza infection enhanced susceptibility to" exact="pneumococcal pneumonia" post="by about 100-fold in a week, but the interaction"/>
 <result pre="studies have shown that influenza infection enhanced susceptibility to pneumococcal" exact="pneumonia" post="by about 100-fold in a week, but the interaction"/>
 <result pre="week, but the interaction between influenza and bacteria is not" exact="limited" post="in pneumococcal pneumonia [13]. In the hospital, viral testing"/>
 <result pre="the interaction between influenza and bacteria is not limited in" exact="pneumococcal pneumonia" post="[13]. In the hospital, viral testing among patients with"/>
 <result pre="interaction between influenza and bacteria is not limited in pneumococcal" exact="pneumonia" post="[13]. In the hospital, viral testing among patients with"/>
 <result pre="is not limited in pneumococcal pneumonia [13]. In the hospital," exact="viral" post="testing among patients with respiratory symptoms is uncommon [14],"/>
 <result pre="pneumonia [13]. In the hospital, viral testing among patients with" exact="respiratory" post="symptoms is uncommon [14], and the determination of the"/>
 <result pre="difficulty of obtaining specimens from the infected area (esp. from" exact="lower" post="respiratory tract), samples could be easily contaminated by respiratory"/>
 <result pre="of obtaining specimens from the infected area (esp. from lower" exact="respiratory" post="tract), samples could be easily contaminated by respiratory conditioned"/>
 <result pre="from lower respiratory tract), samples could be easily contaminated by" exact="respiratory" post="conditioned pathogens. At present, the epidemiological history of influenza-like"/>
 <result pre="viruses other than influenza during an influenza epidemic season were" exact="limited" post="[[15], [16], [17]]. In this study, we report on"/>
 <result pre="[17]]. In this study, we report on the surveillance of" exact="respiratory" post="microorganisms, and its laboratory biomarkers, in CAP patients admitted"/>
 <result pre="city, Guangdong province in China from January to August 2016." exact="Pneumonia" post="was diagnosed as an acute illness with fever, cough,"/>
 <result pre="from January to August 2016. Pneumonia was diagnosed as an" exact="acute" post="illness with fever, cough, or dyspnea / tachypnea, and"/>
 <result pre="cough, or dyspnea / tachypnea, and at least one new" exact="focal" post="chest sign, which was confirmed by finding lung shadowing"/>
 <result pre="or dyspnea / tachypnea, and at least one new focal" exact="chest" post="sign, which was confirmed by finding lung shadowing on"/>
 <result pre="sign, which was confirmed by finding lung shadowing on the" exact="chest" post="radiographs that were likely to be new and without"/>
 <result pre="be new and without other obvious causes [18]. Patients with" exact="cystic fibrosis" post="or HIV infection were excluded from our study. 2.2"/>
 <result pre="without other obvious causes [18]. Patients with cystic fibrosis or" exact="HIV infection" post="were excluded from our study. 2.2 Single-plex real-time PCR"/>
 <result pre="other obvious causes [18]. Patients with cystic fibrosis or HIV" exact="infection" post="were excluded from our study. 2.2 Single-plex real-time PCR"/>
 <result pre="excluded from our study. 2.2 Single-plex real-time PCR assay for" exact="respiratory" post="viruses The sputum specimens were collected and stored in"/>
 <result pre="at −80 °C. The nucleic acid was extracted using a beads" exact="viral" post="DNA/RNA extraction kit (TIANLONG, China) and NP968 nucleic acid"/>
 <result pre="kit (TIANLONG, China) and NP968 nucleic acid extractor (TIANLONG, China)." exact="Respiratory" post="viruses were detected using an AgPath-ID™ One-Step RT-PCR kit"/>
 <result pre="Negativecontrols (DEPC-treated water) were included in each analytical procedure. Fourteen" exact="respiratory" post="viruses including influenza A, influenza B, parainfluenza viruses 1–3"/>
 <result pre="viruses including influenza A, influenza B, parainfluenza viruses 1–3 (PIV1-3)," exact="respiratory" post="syncytial virus (RSV), coronaviruses 229E, OC43, HKU1, and NL63,"/>
 <result pre="were cultured according to China national standard protocols to detect" exact="respiratory" post="bacteria and Yeast. Specimens were inoculated in blood agar,"/>
 <result pre="Compact full automatic identification system (Biomérieux, France). Fourteen bacterium including" exact="Acinetobacter" post="baumannii(A. baumannii), Enterobacter aerogenes(E.aerogenes), Escherichia coli(E.coli), Haemophilus influenzae(H. influenzae),"/>
 <result pre="cases of COPD, 3 cases of tuberculosis, 3 cases of" exact="pulmonary heart disease," post="and 4 cases of emphysema. A total of 106"/>
 <result pre="of COPD, 3 cases of tuberculosis, 3 cases of pulmonary" exact="heart" post="disease, and 4 cases of emphysema. A total of"/>
 <result pre="of pulmonary heart disease, and 4 cases of emphysema. A" exact="total" post="of 106 patients (54.36%) had at least 1 underlying"/>
 <result pre="106 patients (54.36%) had at least 1 underlying disease, including" exact="high blood pressure," post="diabetes, heart disease, epilepsy, tumors and hepatitis. After admission,"/>
 <result pre="at least 1 underlying disease, including high blood pressure, diabetes," exact="heart" post="disease, epilepsy, tumors and hepatitis. After admission, broad-spectrum antibiotics"/>
 <result pre="results of Clinical-laboratory testing. [alt-text] Table 1 　 Cases Percentage" exact="Total" post="195 　 Age 0–14 15 7.69% ≥15 180 92.31%"/>
 <result pre="0–14 15 7.69% ≥15 180 92.31% Gender Male 130 66.67%" exact="Female" post="65 33.33% Pathogen infection Virus 32 16.41% Bacterium 46"/>
 <result pre="180 92.31% Gender Male 130 66.67% Female 65 33.33% Pathogen" exact="infection" post="Virus 32 16.41% Bacterium 46 23.59% Yeast 20 10.26%"/>
 <result pre="17 8.72% Virus+ Yeast 8 4.10% Unidentified 72 36.92% Associated" exact="lung disease" post="COPD 6 3.08% Tuberculosis 3 1.54% Emphysema 4 2.05%"/>
 <result pre="8.72% Virus+ Yeast 8 4.10% Unidentified 72 36.92% Associated lung" exact="disease" post="COPD 6 3.08% Tuberculosis 3 1.54% Emphysema 4 2.05%"/>
 <result pre="4.10% Unidentified 72 36.92% Associated lung disease COPD 6 3.08%" exact="Tuberculosis" post="3 1.54% Emphysema 4 2.05% Pulmonary heart disease 3"/>
 <result pre="disease COPD 6 3.08% Tuberculosis 3 1.54% Emphysema 4 2.05%" exact="Pulmonary" post="heart disease 3 1.54% Asthma 2 1.03% Bronchiectasis 1"/>
 <result pre="COPD 6 3.08% Tuberculosis 3 1.54% Emphysema 4 2.05% Pulmonary" exact="heart" post="disease 3 1.54% Asthma 2 1.03% Bronchiectasis 1 0.51%"/>
 <result pre="6 3.08% Tuberculosis 3 1.54% Emphysema 4 2.05% Pulmonary heart" exact="disease" post="3 1.54% Asthma 2 1.03% Bronchiectasis 1 0.51% Bronchitis"/>
 <result pre="3 1.54% Emphysema 4 2.05% Pulmonary heart disease 3 1.54%" exact="Asthma" post="2 1.03% Bronchiectasis 1 0.51% Bronchitis 1 0.51% Systemic"/>
 <result pre="1.54% Asthma 2 1.03% Bronchiectasis 1 0.51% Bronchitis 1 0.51%" exact="Systemic" post="diseases Diabetes 24 12.31% High blood pressure 54 27.69%"/>
 <result pre="2 1.03% Bronchiectasis 1 0.51% Bronchitis 1 0.51% Systemic diseases" exact="Diabetes" post="24 12.31% High blood pressure 54 27.69% Heart disease"/>
 <result pre="Systemic diseases Diabetes 24 12.31% High blood pressure 54 27.69%" exact="Heart" post="disease 11 5.64% Tumor 6 3.08% Hepatitis 5 2.56%"/>
 <result pre="diseases Diabetes 24 12.31% High blood pressure 54 27.69% Heart" exact="disease" post="11 5.64% Tumor 6 3.08% Hepatitis 5 2.56% Epilepsy"/>
 <result pre="12.31% High blood pressure 54 27.69% Heart disease 11 5.64%" exact="Tumor" post="6 3.08% Hepatitis 5 2.56% Epilepsy 6 3.08% Severity"/>
 <result pre="pressure 54 27.69% Heart disease 11 5.64% Tumor 6 3.08%" exact="Hepatitis" post="5 2.56% Epilepsy 6 3.08% Severity Mild - moderate"/>
 <result pre="Heart disease 11 5.64% Tumor 6 3.08% Hepatitis 5 2.56%" exact="Epilepsy" post="6 3.08% Severity Mild - moderate 95 48.72% Severity"/>
 <result pre="9.23% Antiviral + antibiotic 39 20.00% Clinical symptom Cough 99 50.77% Pharyngeal" exact="discomfort" post="12 6.15% Snivel 9 4.62% Fever 124 63.59% Shortness"/>
 <result pre="Cough 99 50.77% Pharyngeal discomfort 12 6.15% Snivel 9 4.62%" exact="Fever" post="124 63.59% Shortness of breath or dyspnea 59 30.26%"/>
 <result pre="after healing Death 9 4.62% Alive 186 95.38% Abbreviations: COPD," exact="chronic" post="obstructive pulmonary disease. 3.2 Pathogen detection in patients with"/>
 <result pre="Death 9 4.62% Alive 186 95.38% Abbreviations: COPD, chronic obstructive" exact="pulmonary disease." post="3.2 Pathogen detection in patients with CAP A single-bacterial"/>
 <result pre="disease. 3.2 Pathogen detection in patients with CAP A single-bacterial" exact="infection" post="was found in 46 patients (23.59%), a single-Yeast infection"/>
 <result pre="single-bacterial infection was found in 46 patients (23.59%), a single-Yeast" exact="infection" post="was found in 20 patients (10.26%) and a single-viral"/>
 <result pre="infection was found in 20 patients (10.26%) and a single-viral" exact="infection" post="was found in 32 patients (16.41%). Co-infections (virus + bacterium and"/>
 <result pre="could not be unidentified in 72 cases (36.92%) (Table 1)." exact="Bacterial infection" post="was identified in 63 (32.31%) of the 195 patients."/>
 <result pre="not be unidentified in 72 cases (36.92%) (Table 1). Bacterial" exact="infection" post="was identified in 63 (32.31%) of the 195 patients."/>
 <result pre="baumannii and K. pneumoniae, which accounting for 49.21% of the" exact="bacterial infection." post="In addition, there were 7 cases infected by P."/>
 <result pre="E. coli (Table 4). Three cases had more than one" exact="bacterial infection," post="which was S. aureus plus K. ornithinolytica, A. baumannii"/>
 <result pre="plus P. aeruginosa and S. pneumoniae plus E. aerogenes, respectively." exact="Viral infection" post="was identified in 57/195 (29.23%) of the patients. Influenza"/>
 <result pre="P. aeruginosa and S. pneumoniae plus E. aerogenes, respectively. Viral" exact="infection" post="was identified in 57/195 (29.23%) of the patients. Influenza"/>
 <result pre="one virus, accounting for 4.10% of the virus-positive group. Dual" exact="viral infection" post="was observed in RSV co-infected with HRV, PIV3 and"/>
 <result pre="virus, accounting for 4.10% of the virus-positive group. Dual viral" exact="infection" post="was observed in RSV co-infected with HRV, PIV3 and"/>
 <result pre="patients, bacterial/Yeast co-infections with non-influenza viruses were more frequent than" exact="bacterial" post="/Yeast and influenza co-infections (Table 5). 3.3 Clinical presentation"/>
 <result pre="clinical signs observed in 50%, 30.43%, and 23.91% of the" exact="bacterial" post="cases, in 75%, 78.13%, and 34.38% of the viral"/>
 <result pre="the bacterial cases, in 75%, 78.13%, and 34.38% of the" exact="viral" post="cases, in 60%, 35%, and 40% of the Yeast"/>
 <result pre="64%, 68% and 44% of the co-infections cases, respectively. The" exact="bacterial" post="group was significantly different from the viral group and"/>
 <result pre="cases, respectively. The bacterial group was significantly different from the" exact="viral" post="group and the co-infected group in cough (p＜0.0083), at"/>
 <result pre="co-infected group in cough (p＜0.0083), at the same time, the" exact="viral" post="group and the Yeast group in cough also has"/>
 <result pre="Bacterium group Virus group Yeast group Co-infected group p value" exact="Fever" post="23/46 24/32 12/20 16/25 0.166 Cough 14/46** 25/32## 7/20"/>
 <result pre="of breath or dyspnea 11/46 11/32 8/20 11/25 0.317 Pharyngeal" exact="discomfort" post="0/46 5/32 0/20 0/25 — Snivel 1/46 3/32 0/20"/>
 <result pre="level = 0.05/ C 4 2  = 0.0083). 3.4 Etiological type associated with" exact="disease" post="severity and lab findings 4 patients with pure non-influenza"/>
 <result pre="disease severity and lab findings 4 patients with pure non-influenza" exact="infection" post="and 4 patients with non-influenza and bacterium / Yeast"/>
 <result pre="/ Yeast group (Table 3 ). In these patients, pharyngeal" exact="discomfort" post="was only found in the pure influenza group. Bacterium"/>
 <result pre="Non-influ+bacterium /Yeast Clinical symptoms Cough 14/16 11/16 3/5 14/20 Pharyngeal" exact="discomfort" post="5/16 0/16 0/5 0/20 Snivel 2/16 1/16 0/5 0/20"/>
 <result pre="discomfort 5/16 0/16 0/5 0/20 Snivel 2/16 1/16 0/5 0/20" exact="Fever" post="13/16 11/16 2/5 14/20 Shortness of breath 5/16 6/16"/>
 <result pre="neutrophil; PLT, platelet; PH, power of hydrogen; PCO2, carbon dioxide" exact="partial" post="pressure of tension; SO2, oxygen saturation; ICU, intensive care"/>
 <result pre="compared with non-influ + bacterium/ Yeast group. Table 4 The number of" exact="bacterial infections" post="and viral infections in the influenza seasons and non-flu"/>
 <result pre="with non-influ + bacterium/ Yeast group. Table 4 The number of bacterial" exact="infections" post="and viral infections in the influenza seasons and non-flu"/>
 <result pre="Yeast group. Table 4 The number of bacterial infections and" exact="viral" post="infections in the influenza seasons and non-flu seasons in"/>
 <result pre="group. Table 4 The number of bacterial infections and viral" exact="infections" post="in the influenza seasons and non-flu seasons in 2016."/>
 <result pre="and non-flu seasons in 2016. [alt-text] Table 4 Influenza seasons" exact="Total" post="Non-influenza seasons Total Months Jan. Feb. Mar. Apr. May"/>
 <result pre="in 2016. [alt-text] Table 4 Influenza seasons Total Non-influenza seasons" exact="Total" post="Months Jan. Feb. Mar. Apr. May June July Aug."/>
 <result pre="pathogens (K. pneumoniae and PIV2, HKU1). 3.5 The status of" exact="bacterial infections" post="and viral infections in the influenza season and non-flu"/>
 <result pre="(K. pneumoniae and PIV2, HKU1). 3.5 The status of bacterial" exact="infections" post="and viral infections in the influenza season and non-flu"/>
 <result pre="and PIV2, HKU1). 3.5 The status of bacterial infections and" exact="viral" post="infections in the influenza season and non-flu seasons In"/>
 <result pre="PIV2, HKU1). 3.5 The status of bacterial infections and viral" exact="infections" post="in the influenza season and non-flu seasons In the"/>
 <result pre="In the flu season, the cases of A. baumannii 's" exact="infection" post="was greater than those in the non-flu season (15"/>
 <result pre="maltophilia, E. cloacae, K. ornithinolytica, S. marcescens, S. haemolyticus, S." exact="pneumonia" post="were not detected in the non-flu season. The emergence"/>
 <result pre="timely and hence more effective use of drugs, help prevent" exact="secondary" post="spread of infection, all of which shorten hospital stays"/>
 <result pre="stays and have a major impact on patient management and" exact="disease" post="prognosis [[19], [20], [21]]. Accurate and rapid etiologic diagnosis"/>
 <result pre="radiographic findings [22]. The radiological findings of multilobar infiltration or" exact="pleural" post="effusion generally indicate greater severity [23]. Although etiological studies"/>
 <result pre="diagnostic tests frequently do not allow clinicians to rule out" exact="bacterial infection" post="with certainty [24]. Obtaining an qualified sample may be"/>
 <result pre="tests frequently do not allow clinicians to rule out bacterial" exact="infection" post="with certainty [24]. Obtaining an qualified sample may be"/>
 <result pre="as specimens were easily contaminated by the bacteria located in" exact="upper" post="airways [25]. For increasing the detection rate of pathogens,"/>
 <result pre="[25]. For increasing the detection rate of pathogens, esp. for" exact="infection" post="occurred in the lower respiratory tract, alveolar lavage fluid"/>
 <result pre="detection rate of pathogens, esp. for infection occurred in the" exact="lower" post="respiratory tract, alveolar lavage fluid may be better in"/>
 <result pre="rate of pathogens, esp. for infection occurred in the lower" exact="respiratory" post="tract, alveolar lavage fluid may be better in reflecting"/>
 <result pre="respiratory tract, alveolar lavage fluid may be better in reflecting" exact="infectious" post="status than the sputum. However, alveolar lavage fluids require"/>
 <result pre="time PCR assays plus the conventional diagnostic methods, such as" exact="bacterial" post="cultures [26,27]. The single-plex real time PCR assay were"/>
 <result pre="single-plex real time PCR assay were exploited for detecting 14" exact="respiratory" post="viruses, which could improve diagnostic efficacy, particularly in diagnosing"/>
 <result pre="respiratory viruses, which could improve diagnostic efficacy, particularly in diagnosing" exact="respiratory" post="viral infections [28]. Etiologic diagnosis in the CAP patients"/>
 <result pre="viruses, which could improve diagnostic efficacy, particularly in diagnosing respiratory" exact="viral" post="infections [28]. Etiologic diagnosis in the CAP patients reached"/>
 <result pre="which could improve diagnostic efficacy, particularly in diagnosing respiratory viral" exact="infections" post="[28]. Etiologic diagnosis in the CAP patients reached 63.08%,"/>
 <result pre="use of antibiotics prior to sampling may obscure a potential" exact="bacterial" post="detection [29]. Previous studies revealed that etiology remains unknown"/>
 <result pre="patients is challenging. Better diagnostic methods are warranted to distinguish" exact="viral" post="from bacterial CAP, which will clarify if these viral"/>
 <result pre="challenging. Better diagnostic methods are warranted to distinguish viral from" exact="bacterial" post="CAP, which will clarify if these viral infections cause"/>
 <result pre="distinguish viral from bacterial CAP, which will clarify if these" exact="viral" post="infections cause CAP on their own or merely predispose"/>
 <result pre="viral from bacterial CAP, which will clarify if these viral" exact="infections" post="cause CAP on their own or merely predispose the"/>
 <result pre="CAP on their own or merely predispose the patient to" exact="bacterial" post="co-infections [32]. Differences in epidemiology make the knowledge of"/>
 <result pre="there was a severe influenza outbreak during our study, other" exact="respiratory" post="viral infections were more than influenza infection (63.16% vs."/>
 <result pre="was a severe influenza outbreak during our study, other respiratory" exact="viral" post="infections were more than influenza infection (63.16% vs. 36.84%)."/>
 <result pre="a severe influenza outbreak during our study, other respiratory viral" exact="infections" post="were more than influenza infection (63.16% vs. 36.84%). In"/>
 <result pre="our study, other respiratory viral infections were more than influenza" exact="infection" post="(63.16% vs. 36.84%). In all pathogens that cause CAP,"/>
 <result pre="respectively [33]. Although A. baumannii is an important pathogen of" exact="nosocomial infections," post="we often isolated it from infectious patients who is"/>
 <result pre="important pathogen of nosocomial infections, we often isolated it from" exact="infectious" post="patients who is first admitted to the hospital, indicating"/>
 <result pre="popularity in this area. Most community-acquired cases of A. baumannii" exact="pneumonia" post="are from tropical or subtropical countries in the Asia-Pacific"/>
 <result pre="its mortality is 10 times higher than hospital-acquired A. baumannii" exact="pneumonia" post="[33,34]. In another aspect, most of our patients had"/>
 <result pre="we could not exclude the possibility that patients had the" exact="bacterial infection" post="in last hospital admission. The pathogen remains in the"/>
 <result pre="could not exclude the possibility that patients had the bacterial" exact="infection" post="in last hospital admission. The pathogen remains in the"/>
 <result pre="infection in last hospital admission. The pathogen remains in the" exact="respiratory" post="tract, causing clinical symptoms when the body's immunity is"/>
 <result pre="the body's immunity is reduced. The outbreak of A. baumannii" exact="infection" post="is also associated with multidrug resistance, and carbapenems have"/>
 <result pre="be a major factor in resistance to multidrug-resistant A. baumannii" exact="infection" post="[34]. Moreover, the mortality of carbapenem-resistant A. baumannii pneumonia"/>
 <result pre="baumannii infection [34]. Moreover, the mortality of carbapenem-resistant A. baumannii" exact="pneumonia" post="patients is higher than that of carbapenem-sensitive A. baumannii"/>
 <result pre="pneumonia patients is higher than that of carbapenem-sensitive A. baumannii" exact="pneumonia" post="patients [35,36]. S. pneumoniae and H. influenza, as co-pathogens,"/>
 <result pre="as co-pathogens, often seem to be part of a mixed" exact="infection" post="(virus and bacterium) in adults with CAP [26], representing"/>
 <result pre="adults with CAP [26], representing the most common combination with" exact="respiratory" post="viruses [2]. The incidence of mixed infections was significant"/>
 <result pre="common combination with respiratory viruses [2]. The incidence of mixed" exact="infections" post="was significant among patients admitted to the hospital with"/>
 <result pre="of bacterium or Yeast strains expressing factors that enable efficient" exact="disease" post="potentiation during viral epidemics, which should be considered one"/>
 <result pre="Yeast strains expressing factors that enable efficient disease potentiation during" exact="viral" post="epidemics, which should be considered one explanation for regional"/>
 <result pre="etiology of CAP is essential to inform clinical management decisions." exact="Respiratory" post="viruses usually followed seasonal patterns of activity [39], and"/>
 <result pre="from CAP patients contained at least one virus, and dual" exact="infections" post="were very common [40]. The respiratory virus other than"/>
 <result pre="one virus, and dual infections were very common [40]. The" exact="respiratory" post="virus other than influenza accounted for 63.16% viral CAP"/>
 <result pre="[40]. The respiratory virus other than influenza accounted for 63.16%" exact="viral" post="CAP in our study, revealing that respiratory viruses can"/>
 <result pre="accounted for 63.16% viral CAP in our study, revealing that" exact="respiratory" post="viruses can be co-circulating even during the highest epidemic"/>
 <result pre="of influenza that showed a seasonal distribution. Bacterial or fungal" exact="infections" post="secondary to influenza viral infections were common [41], though"/>
 <result pre="influenza that showed a seasonal distribution. Bacterial or fungal infections" exact="secondary" post="to influenza viral infections were common [41], though we"/>
 <result pre="a seasonal distribution. Bacterial or fungal infections secondary to influenza" exact="viral" post="infections were common [41], though we could not exclude"/>
 <result pre="seasonal distribution. Bacterial or fungal infections secondary to influenza viral" exact="infections" post="were common [41], though we could not exclude that"/>
 <result pre="not exclude that the increasing co-infections CAP was due to" exact="secondary" post="viral infection. As the clinical signs and symptoms overlapped"/>
 <result pre="exclude that the increasing co-infections CAP was due to secondary" exact="viral infection." post="As the clinical signs and symptoms overlapped between influenza"/>
 <result pre="treatment is associated with high risk of progression to severe" exact="disease" post="required ICU admission or prolonged hospital stay, and even"/>
 <result pre="host immune response may play a determining role in the" exact="infectious" post="exacerbation of CAP. The intrinsic complexity of the host-microbiome"/>
 <result pre="relationship currently limits the clinical indications of microbiome analysis [25]." exact="Diabetes" post="and high blood pressure were the most common underlying"/>
 <result pre="limits the clinical indications of microbiome analysis [25]. Diabetes and" exact="high blood pressure" post="were the most common underlying disease, which were known"/>
 <result pre="complications and death among critically ill patients [43]. Detection of" exact="respiratory" post="secretions by PCR method has provided a rapid and"/>
 <result pre="the heterogeneity of etiology and the individual host response to" exact="infection" post="[45]. Funding This research did not receive any specific"/>
 <result pre="The authors declare that the research was conducted in the" exact="absence of" post="any commercial or financial relationships that could be construed"/>
 <result pre="interest. References References 1SpindlerC.StralinK.ErikssonL.Swedish guidelines on the management of community-acquired" exact="pneumonia" post="in immunocompetent adults—Swedish Society of Infectious Diseases 2012Scand. J."/>
 <result pre="the management of community-acquired pneumonia in immunocompetent adults—Swedish Society of" exact="Infectious" post="Diseases 2012Scand. J. Infect. Dis.44201288590222830356 2GadsbyN.J.RussellC.D.McHughM.P.Comprehensive molecular testing for"/>
 <result pre="management of community-acquired pneumonia in immunocompetent adults—Swedish Society of Infectious" exact="Diseases" post="2012Scand. J. Infect. Dis.44201288590222830356 2GadsbyN.J.RussellC.D.McHughM.P.Comprehensive molecular testing for respiratory"/>
 <result pre="Infectious Diseases 2012Scand. J. Infect. Dis.44201288590222830356 2GadsbyN.J.RussellC.D.McHughM.P.Comprehensive molecular testing for" exact="respiratory" post="pathogens in community-acquired pneumoniaClin. Infect. Dis.62201681782326747825 3BabadyN.E.MeadP.StilesJ.Comparison of the"/>
 <result pre="and the Idaho Technology FilmArray RP assay for detection of" exact="respiratory" post="viruses in pediatric patients at a cancer hospitalJ. Clin."/>
 <result pre="for detection of respiratory viruses in pediatric patients at a" exact="cancer" post="hospitalJ. Clin. Microbiol.5020122282228822518855 4WHOInfluenza (seasonal) Fact Sheet No 211."/>
 <result pre="211. 2009Available from:2009http://www.who.int/mediacentre/factsheets/fs211/en/index.html 5CuiL.ZhengD.LeeY.H.Metabolomics investigation reveals metabolite mediators associated with" exact="acute" post="lung injury and repair in a murine model of"/>
 <result pre="a murine model of influenza pneumoniaSci. Rep.620162607627188343 6NorowitzY.M.KohlhoffS.Smith-NorowitzT.A.Relationship of influenza" exact="virus infection" post="to associated infections in children who present with influenza-like"/>
 <result pre="murine model of influenza pneumoniaSci. Rep.620162607627188343 6NorowitzY.M.KohlhoffS.Smith-NorowitzT.A.Relationship of influenza virus" exact="infection" post="to associated infections in children who present with influenza-like"/>
 <result pre="influenza pneumoniaSci. Rep.620162607627188343 6NorowitzY.M.KohlhoffS.Smith-NorowitzT.A.Relationship of influenza virus infection to associated" exact="infections" post="in children who present with influenza-like symptomsBMC Infect. Dis.16201630427317396"/>
 <result pre="pairings drive clinical outcomes of pneumonia?Clin. Microbiol. Infect.19201311311823231363 9BoschA.A.BiesbroekG.TrzcinskiK.Viral and" exact="bacterial" post="interactions in the upper respiratory tractPLoS Pathog.92013e1003057 10FalseyA.R.BeckerK.L.SwinburneA.J.Bacterial complications"/>
 <result pre="of pneumonia?Clin. Microbiol. Infect.19201311311823231363 9BoschA.A.BiesbroekG.TrzcinskiK.Viral and bacterial interactions in the" exact="upper" post="respiratory tractPLoS Pathog.92013e1003057 10FalseyA.R.BeckerK.L.SwinburneA.J.Bacterial complications of respiratory tract viral"/>
 <result pre="pneumonia?Clin. Microbiol. Infect.19201311311823231363 9BoschA.A.BiesbroekG.TrzcinskiK.Viral and bacterial interactions in the upper" exact="respiratory" post="tractPLoS Pathog.92013e1003057 10FalseyA.R.BeckerK.L.SwinburneA.J.Bacterial complications of respiratory tract viral illness:"/>
 <result pre="interactions in the upper respiratory tractPLoS Pathog.92013e1003057 10FalseyA.R.BeckerK.L.SwinburneA.J.Bacterial complications of" exact="respiratory" post="tract viral illness: a comprehensive evaluationJ. Infect. Dis.208201343244123661797 11McCullersJ.A.The"/>
 <result pre="the upper respiratory tractPLoS Pathog.92013e1003057 10FalseyA.R.BeckerK.L.SwinburneA.J.Bacterial complications of respiratory tract" exact="viral" post="illness: a comprehensive evaluationJ. Infect. Dis.208201343244123661797 11McCullersJ.A.The co-pathogenesis of"/>
 <result pre="the lungNat. Rev. Microbiol.12201425226224590244 12van der SluijsK.F.van der PollT.LutterR.Bench-to-bedside review:" exact="bacterial" post="pneumonia with influenza - pathogenesis and clinical implicationsCrit Care14201021920459593"/>
 <result pre="lungNat. Rev. Microbiol.12201425226224590244 12van der SluijsK.F.van der PollT.LutterR.Bench-to-bedside review: bacterial" exact="pneumonia" post="with influenza - pathogenesis and clinical implicationsCrit Care14201021920459593 13ShresthaS.FoxmanB.WeinbergerD.M.Identifying"/>
 <result pre="and clinical implicationsCrit Care14201021920459593 13ShresthaS.FoxmanB.WeinbergerD.M.Identifying the interaction between influenza and" exact="pneumococcal pneumonia" post="using incidence dataSci. Transl. Med.52013191ra84 14JuX.FangQ.ZhangJ.Viral etiology of influenza-like"/>
 <result pre="clinical implicationsCrit Care14201021920459593 13ShresthaS.FoxmanB.WeinbergerD.M.Identifying the interaction between influenza and pneumococcal" exact="pneumonia" post="using incidence dataSci. Transl. Med.52013191ra84 14JuX.FangQ.ZhangJ.Viral etiology of influenza-like"/>
 <result pre="2010 to May 2011PLoS One72012e28786 18WoodheadM.BlasiF.EwigS.Guidelines for the management of" exact="adult" post="lower respiratory tract infections—summaryClin. Microbiol. Infect.17Suppl 62011124 19LoeffelholzM.J.PongD.L.PylesR.B.Comparison of"/>
 <result pre="to May 2011PLoS One72012e28786 18WoodheadM.BlasiF.EwigS.Guidelines for the management of adult" exact="lower" post="respiratory tract infections—summaryClin. Microbiol. Infect.17Suppl 62011124 19LoeffelholzM.J.PongD.L.PylesR.B.Comparison of the"/>
 <result pre="May 2011PLoS One72012e28786 18WoodheadM.BlasiF.EwigS.Guidelines for the management of adult lower" exact="respiratory" post="tract infections—summaryClin. Microbiol. Infect.17Suppl 62011124 19LoeffelholzM.J.PongD.L.PylesR.B.Comparison of the FilmArray"/>
 <result pre="respiratory tract infections—summaryClin. Microbiol. Infect.17Suppl 62011124 19LoeffelholzM.J.PongD.L.PylesR.B.Comparison of the FilmArray" exact="Respiratory" post="Panel and Prodesse real-time PCR assays for detection of"/>
 <result pre="Respiratory Panel and Prodesse real-time PCR assays for detection of" exact="respiratory" post="pathogensJ. Clin. Microbiol.4920114083408821998418 20ByingtonC.L.CastilloH.GerberK.The effect of rapid respiratory viral"/>
 <result pre="detection of respiratory pathogensJ. Clin. Microbiol.4920114083408821998418 20ByingtonC.L.CastilloH.GerberK.The effect of rapid" exact="respiratory" post="viral diagnostic testing on antibiotic use in a children’s"/>
 <result pre="of respiratory pathogensJ. Clin. Microbiol.4920114083408821998418 20ByingtonC.L.CastilloH.GerberK.The effect of rapid respiratory" exact="viral" post="diagnostic testing on antibiotic use in a children’s hospitalArch."/>
 <result pre="hospitalArch. Pediatr. Adolesc. Med.15620021230123412444835 21FileT.M.Community-acquired pneumoniaLancet36220031991200114683661 22CherianT.MulhollandE.K.CarlinJ.B.Standardized interpretation of paediatric" exact="chest" post="radiographs for the diagnosis of pneumonia in epidemiological studiesBull."/>
 <result pre="22CherianT.MulhollandE.K.CarlinJ.B.Standardized interpretation of paediatric chest radiographs for the diagnosis of" exact="pneumonia" post="in epidemiological studiesBull. World Health Organ.83200535335915976876 23MandellL.A.WunderinkR.G.AnzuetoA.Infectious Diseases Society"/>
 <result pre="diagnosis of pneumonia in epidemiological studiesBull. World Health Organ.83200535335915976876 23MandellL.A.WunderinkR.G.AnzuetoA.Infectious" exact="Diseases" post="Society of America/American Thoracic Society consensus guidelines on the"/>
 <result pre="epidemiological studiesBull. World Health Organ.83200535335915976876 23MandellL.A.WunderinkR.G.AnzuetoA.Infectious Diseases Society of America/American" exact="Thoracic" post="Society consensus guidelines on the management of community-acquired pneumonia"/>
 <result pre="America/American Thoracic Society consensus guidelines on the management of community-acquired" exact="pneumonia" post="in adultsClin. Infect. Dis.44Suppl 22007S277217278083 24BartlettJ.G.Diagnostic tests for agents"/>
 <result pre="agents of community-acquired pneumoniaClin. Infect. Dis.52Suppl 42011S29630421460288 25PirroneM.PinciroliR.BerraL.Microbiome, biofilms, and" exact="pneumonia" post="in the ICUCurr. Opin. Infect. Dis.29201616016626855081 26JohanssonN.KalinM.Tiveljung-LindellA.Etiology of community-acquired"/>
 <result pre="increased microbiological yield with new diagnostic methodsClin. Infect. Dis.50201020220920014950 27LuchsingerV.RuizM.ZuninoE.Community-acquired" exact="pneumonia" post="in Chile: the clinical relevance in the detection of"/>
 <result pre="Chile: the clinical relevance in the detection of viruses and" exact="atypical" post="bacteriaThorax6820131000100623783373 28HolterJ.C.MullerF.BjorangO.Etiology of community-acquired pneumonia and diagnostic yields of"/>
 <result pre="the detection of viruses and atypical bacteriaThorax6820131000100623783373 28HolterJ.C.MullerF.BjorangO.Etiology of community-acquired" exact="pneumonia" post="and diagnostic yields of microbiological methods: a 3-year prospective"/>
 <result pre="May–August 2009MMWR Morb. Mortal. Wkly. Rep.5820091071107419798021 30JokinenC.HeiskanenL.JuvonenH.Microbial etiology of community-acquired" exact="pneumonia" post="in the adult population of 4 municipalities in eastern"/>
 <result pre="Mortal. Wkly. Rep.5820091071107419798021 30JokinenC.HeiskanenL.JuvonenH.Microbial etiology of community-acquired pneumonia in the" exact="adult" post="population of 4 municipalities in eastern FinlandClin. Infect. Dis.3220011141115411283803"/>
 <result pre="of care C. BTS guidelines for the management of community" exact="acquired" post="pneumonia in adultsThorax56Suppl 42001IV16411713364 32RhedinS.LindstrandA.HjelmgrenA.Respiratory viruses associated with community-acquired"/>
 <result pre="care C. BTS guidelines for the management of community acquired" exact="pneumonia" post="in adultsThorax56Suppl 42001IV16411713364 32RhedinS.LindstrandA.HjelmgrenA.Respiratory viruses associated with community-acquired pneumonia"/>
 <result pre="acquired pneumonia in adultsThorax56Suppl 42001IV16411713364 32RhedinS.LindstrandA.HjelmgrenA.Respiratory viruses associated with community-acquired" exact="pneumonia" post="in children: matched case-control studyThorax70201584785326077969 33BachoumasK.LebertC.LacheradeJ.C.Community-acquired Acinetobacter baumannii pneumoniaMed."/>
 <result pre="associated with community-acquired pneumonia in children: matched case-control studyThorax70201584785326077969 33BachoumasK.LebertC.LacheradeJ.C.Community-acquired" exact="Acinetobacter" post="baumannii pneumoniaMed. Mal. Infect.45201533733926141128 34AntunesL.C.ViscaP.TownerK.J.Acinetobacter baumannii: evolution of a"/>
 <result pre="of a global pathogenPathog. Dis.71201429230124376225 35LiY.J.PanC.Z.FangC.Q.Pneumonia caused by extensive drug-resistant" exact="Acinetobacter" post="baumannii among hospitalized patients: genetic relationships, risk factors and"/>
 <result pre="factors and mortalityBMC Infect. Dis.17201737128558660 36TengS.O.YenM.Y.OuT.Y.Comparison of pneumonia- and non-pneumonia-related" exact="Acinetobacter" post="baumannii bacteremia: impact on empiric therapy and antibiotic resistanceJ."/>
 <result pre="C. British thoracic society guidelines for the management of community" exact="acquired" post="pneumonia in childhoodThorax57Suppl 12002i12411994552 39RuuskanenO.LahtiE.JenningsL.C.Viral pneumoniaLancet37720111264127521435708 40MengelleC.MansuyJ.M.PierreA.The use of"/>
 <result pre="British thoracic society guidelines for the management of community acquired" exact="pneumonia" post="in childhoodThorax57Suppl 12002i12411994552 39RuuskanenO.LahtiE.JenningsL.C.Viral pneumoniaLancet37720111264127521435708 40MengelleC.MansuyJ.M.PierreA.The use of a"/>
 <result pre="40MengelleC.MansuyJ.M.PierreA.The use of a multiplex real-time PCR assay for diagnosing" exact="acute" post="respiratory viral infections in children attending an emergency unitJ."/>
 <result pre="use of a multiplex real-time PCR assay for diagnosing acute" exact="respiratory" post="viral infections in children attending an emergency unitJ. Clin."/>
 <result pre="of a multiplex real-time PCR assay for diagnosing acute respiratory" exact="viral" post="infections in children attending an emergency unitJ. Clin. Virol.61201441141725223920"/>
 <result pre="a multiplex real-time PCR assay for diagnosing acute respiratory viral" exact="infections" post="in children attending an emergency unitJ. Clin. Virol.61201441141725223920 41RiceT.W.RubinsonL.UyekiT.M.Critical"/>
 <result pre="Virol.61201441141725223920 41RiceT.W.RubinsonL.UyekiT.M.Critical illness from 2009 pandemic influenza A virus and" exact="bacterial" post="coinfection in the United StatesCrit. Care Med.4020121487149822511131 42ChienY.S.SuC.P.TsaiH.T.Predictors and"/>
 <result pre="in the United StatesCrit. Care Med.4020121487149822511131 42ChienY.S.SuC.P.TsaiH.T.Predictors and outcomes of" exact="respiratory" post="failure among hospitalized pneumonia patients with 2009 H1N1 influenza"/>
 <result pre="Care Med.4020121487149822511131 42ChienY.S.SuC.P.TsaiH.T.Predictors and outcomes of respiratory failure among hospitalized" exact="pneumonia" post="patients with 2009 H1N1 influenza in TaiwanJ. Infect.60201016817420036689 43BagshawS.M.EgiM.GeorgeC.Early"/>
 <result pre="ill patients in AustraliaCrit. Care Med.37200946347019114915 44CunhaB.A.IrshadN.ConnollyJ.J.Adult human metapneumonovirus (hMPV)" exact="pneumonia" post="mimicking Legionnaire’s diseaseHeart Lung45201627027226988110 45DavenportE.E.BurnhamK.L.RadhakrishnanJ.Genomic landscape of the individual"/>
 <result pre="study was made possible by the generous support of the" exact="American" post="people through the United States Agency for International Development"/>
</results>
